City of Hope CAR-T Scientist Christine Brown and Team Receive $12.8 Million Grant from California’s Stem Cell … – Business Wire (press release)
Business Wire (press release) |
City of Hope CAR–T Scientist Christine Brown and Team Receive $12.8 Million Grant from California’s Stem Cell …
Business Wire (press release) CAR–T cells, a type of immunotherapy, are a cell-based therapy in which a patient’s own T cells are reprogrammed to actively seek out and destroy malignant cells. Few effective therapies currently exist for malignant glioma, which has a five-year … |
Regulatory Focus |
New California Law Requires Posted Notices of Non-FDA Approved Stem Cell Products
Regulatory Focus California’s SB 512, which requires any health provider administering non-FDA approved stem cell treatments to post a notice and provide a handout about how the procedure has not been approved by FDA, also would impose maximum fines of $1,000 for … |
Regulatory Focus |
New California Law Requires Posted Notices of Non-FDA Approved Stem Cell Products
Regulatory Focus California’s SB 512, which requires any health provider administering non-FDA approved stem cell treatments to post a notice and provide a handout about how the procedure has not been approved by FDA, also would impose maximum fines of $1,000 for … UC Davis grant aims to speed development, delivery of stem–cell therapiesDavis Enterprise |
Waco Tribune-Herald |
Gene therapy helps boys with “Lorenzo’s Oil” disease
Waco Tribune-Herald Study results published Wednesday, Oct. 4, 2017, by the New England Journal of Medicine showed an experimental gene therapy treatment seemed to help boys with the inherited nerve disease featured in the movie “Lorenzo’s Oil.” Although the news is … |
CTV News |
Gene therapy helps boys with ‘Lorenzo’s Oil’ disease | CTV News
CTV News The fledgling field of gene therapy has scored another win: An experimental treatment seemed to help boys with the inherited nerve disease featured in the … |
|
Chimeric Antigen Receptor (CAR) T cell Immunotherapy– Competitive Landscape, Technology and Pipeline Analysis …
Markets Insider LONDON, Oct. 4, 2017 /PRNewswire/ — DelveInsight’s, “Chimeric Antigen Receptor (CAR) T cell Immunotherapy– Competitive Landscape, Pipeline and Market Analysis, 2017″, report provides comprehensive insights about marketed and pipeline drugs … |